17:45 ETFederal Law Brings Hope to Individuals and Families Living with SMA, Expands Access and Research
I'm PortAI, I can summarize articles.
Cure SMA announced that key research and legislative priorities for spinal muscular atrophy (SMA) have been approved by Congress and signed into law as part of the Consolidated Appropriations Act of 2026. This law increases federal research funding, extends the Rare Pediatric Disease Priority Review Voucher Program, and improves access to specialized care for individuals with SMA. These provisions aim to enhance the lives of the 10,000 individuals living with SMA in the U.S. and support innovation in treatment and care.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: prnewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments